Form 4: Tandem Diabetes Care COO Reports Stock Transaction
Insider Transaction (Form 4)
Jean-Claude Kyrillos, EVP & Chief Operating Officer of Tandem Diabetes Care Inc, reported multiple transactions in common stock on October 15, 2026.
Summary
- Option exercise/conversion: acquired 3,637 Common Stock on October 15, 2026; holds 33,927 after (Direct).
- Tax/exercise-price withholding: disposed of 1,926 Common Stock at $16.52 ($31,818) on October 15, 2026; holds 32,001 after (Direct).
- Option exercise/conversion: disposed of 3,637 Restricted Stock Unit on October 15, 2026; holds 10,908 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jean-Claude Kyrillos — Officer (EVP & Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Common Stock | 3,637 | — | — | 33,927 |
| 2026-10-15 | Tax/exercise-price withholding | Common Stock | 1,926 | $17 | $31.8K | 32,001 |
| 2026-10-15 | Option exercise/conversion | Restricted Stock Unit | 3,637 | — | — | 10,908 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (3,637 shares) |
| 2026-10-15 | Tax/exercise-price withholding (1,926 shares) |
| 2026-10-15 | Option exercise/conversion (3,637 shares) |
Keywords
insider transaction, Form 4, TNDM, TANDEM DIABETES CARE INC, neutral, Jean-Claude Kyrillos
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.